日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination

通过尝试以蛋白质为模板的还原胺化反应优化MDM2抑制剂

van der Vlag, Ramon; Yagiz Unver, M; Felicetti, Tommaso; Twarda-Clapa, Aleksandra; Kassim, Fatima; Ermis, Cagdas; Neochoritis, Constantinos G; Musielak, Bogdan; Labuzek, Beata; Dömling, Alexander; Holak, Tad A; Hirsch, Anna K H

A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells

一种基于氟化吲哚的MDM2拮抗剂选择性抑制p53wt骨肉瘤细胞的生长

Lukasz Skalniak ,Aleksandra Twarda-Clapa ,Constantinos G Neochoritis ,Ewa Surmiak ,Monika Machula ,Aneta Wisniewska ,Beata Labuzek ,Ameena M Ali ,Sylwia Krzanik ,Grzegorz Dubin ,Matthew Groves ,Alexander Dömling ,Tad A Holak

Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis

非靶向血浆代谢组学鉴定出多发性硬化症慢性动物模型中具有类药物特性的内源性代谢物

Laila M Poisson, Hamid Suhail, Jaspreet Singh, Indrani Datta, Aleksandar Denic, Krzysztof Labuzek, Md Nasrul Hoda, Ashray Shankar, Ashok Kumar, Mirela Cerghet, Stanton Elias, Robert P Mohney, Moses Rodriguez, Ramandeep Rattan, Ashutosh K Mangalam, Shailendra Giri1